Test positivity rate: How this one figure explains that the US isn't doing enough testing yet

Test positivity rates measure the success of a testing program. Even though the US performs a huge number of tests, high test positivity rates across the country show that that it still isn't enough.

Ronald D. Fricker, Jr., Professor of Statistics and Associate Dean for Faculty Affairs and Administration, Virginia Tech • conversation
July 30, 2020 ~7 min

Tags: health covid-19 coronavirus pandemic donald-trump sars-cov-2 outbreak testing epidemics coronavirus-testing asymptomatic

A restart of nuclear testing offers little scientific value to the US and would benefit other countries

Seventy-five years after the first nuclear detonation and nearly 30 years since testing was banned, the US is considering resuming live nuclear testing.

Miles A. Pomper, Senior Fellow, James Martin Center for Nonproliferation Studies, Middlebury • conversation
July 14, 2020 ~10 min

Tags: donald-trump radiation nuclear-tests nuclear-weapons plutonium comprehensive-test-ban-treaty

When Trump pushed hydroxychloroquine to treat COVID-19, hundreds of thousands of prescriptions followed despite little evidence that it worked

When news reports tout a drug, people get interested, even if the benefits are unproven. Patient hopes, requests and demands can easily turn into real prescriptions in their doctor's office.

Richard L. Kravitz, Professor of Health Policy and Internal Medicine, University of California, Davis • conversation
July 9, 2020 ~10 min

Tags: drugs covid-19 coronavirus donald-trump hydroxychloroquine prescribing chloroquine medication prescription-drugs medications fox-news new-york-times doctor-prescribing off-label-prescribing

5 COVID-19 myths politicians have repeated that just aren't true

The purveyors of these myths, including politicians who have been soft peddling the impact of the coronavirus, aren't doing the country any favors.

Geoffrey Joyce, Director of Health Policy, USC Schaeffer Center, and Associate Professor, University of Southern California • conversation
July 8, 2020 ~8 min

Tags:  health  covid-19  coronavirus  brazil  donald-trump  herd-immunity  economy  misinformation  jair-bolsonaro  cdc  myths  denial

TikTok teens and the Trump campaign: How social media amplifies political activism and threatens election integrity

If teenagers organizing on social media can hamper a presidential campaign rally, how challenging is it to manipulate elections?

Anjana Susarla, Associate Professor of Information Systems, Michigan State University • conversation
June 30, 2020 ~7 min

Tags: social-media politics donald-trump activism political-activism black-lives-matter campaigning k-pop filter-bubble tiktok political-campaigns

National parks – even Mount Rushmore – show that there's more than one kind of patriotism

President Trump is scheduled to appear at an Independence Day celebration at Mount Rushmore on July 3. For some, this event will symbolize love of country. Others will see it very differently.

Jennifer Ladino, Professor of English, University of Idaho • conversation
June 29, 2020 ~9 min

Tags: covid-19 donald-trump japanese-internment-camps california us-history national-parks patriotism reconciliation independence-day july-4 south-dakota

Conservation could create jobs post-pandemic

The Trump administration is rolling back environmental regulations, claiming it's good for the economy. But research shows that conservation is better both for public health and for job creation.

Heidi Peltier, Research Professor in Political Science; Faculty Research Fellow at the Pardee Center for the Study of the Longer-Range Future, Boston University • conversation
June 18, 2020 ~6 min

Tags: energy environment conservation politics funding donald-trump economy jobs parks trump-administration research clean-energy forestry job-creation environmental-protections

Could pressure for COVID-19 drugs lead the FDA to lower its standards?

The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?

Leigh Turner, Associate Professor, University of Minnesota Center for Bioethics, School of Public Health, & College of Pharmacy, University of Minnesota • conversation
June 10, 2020 ~10 min

Tags:  covid-19  coronavirus  pandemic  donald-trump  fda  food-and-drug-administration  hydroxychloroquine  clinical-trials  oversight

Hydroxychloroquine for COVID-19: A new review of several studies shows flaws in research and no benefit

Our expert assessed all the controlled studies so far on hydroxychloroquine. His findings may surprise you.

C. Michael White, Professor and Head of the Department of Pharmacy Practice, University of Connecticut • conversation
May 28, 2020 ~7 min

Tags:  covid-19  coronavirus  pandemic  donald-trump  viruses  hydroxychloroquine  clinical-trials

Coronavirus reminds you of death – and amplifies your core values, both bad and good

It's human nature to try to insulate yourself from the unpleasant realization that death comes for all of us eventually.

Sheldon Solomon, Professor of Psychology, Skidmore College • conversation
May 21, 2020 ~9 min

Tags: covid-19 coronavirus death psychology pandemic social-psychology donald-trump fear sars-cov-2 covid-19-pandemic behavior attitudes fear-of-death fears existential-anxiety

Page 1 of 2